- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharmesis International Ltd (PHAR)
Pharmesis International Ltd stock price live, this page displays SGX PHAR stock exchange data. View the PHAR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pharmesis International Ltd real time stock price chart below.
What Is the Pharmesis International Ltd Stock Price Today?
The Pharmesis International Ltd stock price today is 0.125.
What Is the Stock Symbol for Pharmesis International Ltd?
The stock symbol for Pharmesis International Ltd is "PHAR."
What Stock Exchange Does Pharmesis International Ltd Trade On?
Pharmesis International Ltd is listed and trades on the Singapore stock exchange.
Is Pharmesis International Ltd a Good Stock to Buy?
Determining whether Pharmesis International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHAR quote. (ISIN: SG1BH6000003)
What Is the Pharmesis International Ltd Stock Price Today?
The Pharmesis International Ltd stock price today is 0.125.
What Is the Stock Symbol for Pharmesis International Ltd?
The stock symbol for Pharmesis International Ltd is "PHAR."
What Stock Exchange Does Pharmesis International Ltd Trade On?
Pharmesis International Ltd is listed and trades on the Singapore stock exchange.
Is Pharmesis International Ltd a Good Stock to Buy?
Determining whether Pharmesis International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHAR quote. (ISIN: SG1BH6000003)
Singapore
Currency in SGD
0.125
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.117
0.152
52 wk Range
0.077
0.450
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1170.152
52 wk Range
0.0770.450
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(8.00%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(8.00%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PHAR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Pays a significant dividend to shareholders
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-0.14 / --
Revenue / Forecast
11.87M / --
Compare PHAR to Peers and Sector
Metrics to compare | PHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHARPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | −13.4x | −0.4x | |
PEG Ratio | 0.02 | 0.11 | 0.00 | |
Price/Book | 0.4x | 1.7x | 2.6x | |
Price / LTM Sales | 0.7x | 4.7x | 3.0x | |
Upside (Analyst Target) | - | 50.0% | 56.0% | |
Fair Value Upside | Unlock | −14.3% | 8.7% | Unlock |
Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs. The company offers Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for rheumatoid arthritis and other rheumatic diseases treatment. It also provides Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice and clear heat toxin; Shulinghou for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Fu Yang for the treatment skin pruritus and urticaria; and Xiong Dan Chuan Bei for the treatment of phlegm and cough. Further, the company distributes chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. The company provides western medicine products under the Kinna brand name; and TCM formulated products under the Longlife brand name. Pharmesis International Ltd. was founded in 1996 and is based in Singapore.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Pharmesis International Ltd (PHAR) Stock Price Today?
The Pharmesis International Ltd stock price today is 0.125 SGD.
What Stock Exchange Does Pharmesis International Ltd Trade On?
Pharmesis International Ltd is listed and trades on the Singapore Stock Exchange.
What Is the Stock Symbol for Pharmesis International Ltd?
The stock symbol for Pharmesis International Ltd is "PHAR."
Does Pharmesis International Ltd Pay Dividends? What’s The Current Dividend Yield?
The Pharmesis International Ltd dividend yield is 8%.
What Is the Pharmesis International Ltd Market Cap?
As of today, Pharmesis International Ltd market cap is 3.960M SGD.
What Is Pharmesis International Ltd's Earnings Per Share (TTM)?
The Pharmesis International Ltd EPS (TTM) is -0.230.
From a Technical Analysis Perspective, Is PHAR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Pharmesis International Ltd Stock Split?
Pharmesis International Ltd has split 1 times.
How Many Employees Does Pharmesis International Ltd Have?
Pharmesis International Ltd has 1096 employees.
What is the current trading status of Pharmesis International Ltd (PHAR)?
As of Sep 16, 2026, Pharmesis International Ltd (PHAR) is trading at a price of 0.125 SGD, with a previous close of 0.125 SGD. The stock has fluctuated within a day range of 0.117 SGD to 0.152 SGD, while its 52-week range spans from 0.077 SGD to 0.450 SGD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.